Clinical Trial Update: Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravitreal ranibizumab versus laser therapy for diabetic macular edema reported efficacy and safety results with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Macular Edema, Visual Impairment | Phase 2 | Status: COMPLETED | Results posted: 2014-07-03